|
 |
European BioPharmaceutical Review
|
| World demand for transgenic seeds is projected to advance by 12 per cent annually to $3.8 billion in 2006. Arable land devoted to transgenic crops is expected to increase by 7.2 per cent per year to 184 million acres over the same period. Cultivation of transgenic crops will continue to be dominated by the United States, with Argentina, Canada and China generating the largest demand among other countries. Together, these four countries will account for nearly 85 per cent of total global transgenic seed sales in 2006. China, fuelled by external investment and government support, will generate the fastest growth among all agricultural biotechnology markets and will emerge as one of the most diversified producers of transgenic crops. Three crops - soybeans, corn and cotton - will continue to make up almost 90 per cent of global demand for genetically modified (GM) seeds throughout 2006. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By William Martineau, Senior Research Analyst at The Freedonia Group, Inc
William Martineau is Senior Research Analyst at The Freedonia Group, Inc. Mr Martineau has written studies for Freedonia for over 15 years. He has performed in-depth research in areas of biotechnology, pharmaceuticals, medical packaging and related areas, producing titles such as Pharmaceutical Chemicals, U.S. Pharmaceutical Packaging, World Pharmaceutical Packaging, World Pharmaceuticals I & II, Medical Testing Chemicals, Drug Delivery Systems, and Biotechnology. Prior to joining Freedonia, Mr Martineau was Manager of Market Development at American Sterilizer Company where he gained experience in health care research and strategic planning. At Invenex Laboratories, he served as Product Manager responsible for the administration of a line of injectable pharmaceuticals. He has also served as Senior Health Care Analyst at Predicasts Inc and as Manager of Market Research at Life Technologies Inc (a division of The Dexter Corporation). Mr Martineau holds a BA in Management and a MBA in Marketing and Finance from Kent State University.
|
|
|
|
|
|
 |
Industry Events |
 |
FT Global Pharmaceutical and Biotechnology Conference 2008
2-3 December 2008, The Cumberland, London
FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >> |
|
 |
News and Press Releases |
 |
Stora Enso with DDSi is Winner of HCPC-Europe Packaging Award 2008
11th November 2008
More info >> |
|
 |
